Skip to main content

GILD Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Gilead Sciences Inc. News

Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact

Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.

Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?

Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning.

Cramer's Mad Money Recap 3/18: Nike, Nvidia, Adobe

Game plan for the week ahead with earnings from Nike, Adobe, KB Home and a keynote from Nvidia's CEO.

Cramer's Mad Money Recap 2/4: Take-Two Interactive, Disney, Twitter

Earnings from Take-Two Interactive, Disney and Twitter highlight Jim Cramer's game plan for next week.

Gilead Sciences Sues to Block Sellers of Counterfeit HIV Meds

Gilead Sciences uncovered a network that sold some $250 million of counterfeit versions of its HIV medications, a media report says.

Breaking News

Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests

Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.

Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat

"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.

Playtika Stock Surges On Report of Joffre Capital Interest in Online Casino Gaming Group

Axios reported late Monday that tech buyout group Joffre Capital is seeking a majority stake in the online casino video game group.